Launched in Southampton, the three-year scheme is a collaboration between the University of Southampton and Keele.

Research team from the universities of Southampton and Keele, working alongside the NHS and Versus Arthritis A new project ...

The project builds on a recent pilot study, also led by Prof Pincus, called De-Stress Pain. It focused on improving wellbeing ...

Childhood trauma is linked to mental health problems and chronic pain in later life and is a leading driver of health ...

Patients with PsA have a higher prevalence of MetS compared with members of the general population and individuals with other inflammatory arthropathies.

Patients with D2T-PsA can be stratified into inflammatory and noninflammatory phenotypes, with the former linked to higher sonographic activity.

In adults with early PsA, golimumab with methotrexate and corticosteroids shows no significant difference in improving PsA ...

Back pain is rarely “just back pain.” Research shows it often comes with heart disease, arthritis, depression, or other chronic illnesses.

Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA® ...

When it comes to low impact fitness activities, walking and jogging are something most of us can do, without too much effort.

Delaying MTX initiation by 4 weeks after PCV13 vaccination significantly improved humoral responses in patients with RA, without compromising disease control.

Recently, researchers in Australia tested baricitinib, a drug used for rheumatoid arthritis, in people newly diagnosed with Type‑1 diabetes, showing promising results for early intervention.